NCT05404490

Efficacy of Bupivacain Local Infiltration for the Management of Pain During Cesarean Section

Efficacy of Bupivacain Local Infiltration for the Management of Pain During Cesarean Section. Randomized, Single Blind, Controlled Trial

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 202 (actual)
• Sponsor: Saint Thomas Hospital, Panama · Academic / Other
• Sex: Female
• Age: —
• Healthy volunteers: Not accepted

Summary

This study aims to evaluate the effect of local administration of bupivacain in the cesarean section incision for postoperative pain control, using the visual analogue pain scale (VAS) and assessing the need for rescue analgesia after surgery.

Conditions

• Pain, Postoperative

Interventions

Type	Name	Description
DRUG	Bupivacain	20 mL of bupivacaine 0.5% will be infiltrated. 10 mL will be infiltrated in the inferior border and 10 mL in the superior border of the subcutaneous cellular tissue.
DRUG	Placebo	20 mL of Normal Saline Solution will be infiltrated. 10 mL will be infiltrated in the inferior border and 10 mL in the superior border of the subcutaneous cellular tissue.

Timeline

• Start date: 2022-06-01
• Primary completion: 2022-10-31
• Completion: 2022-11-30
• First posted: 2022-06-03
• Last updated: 2025-08-26

Locations

1 site across 1 country: Panama